The Stem Cell Blog – Page 1452

Cellectis wins European patent for CRISPR use in T-cells – News-Medical.net

2017-07-25 Michael Zand NEWS

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina – Science Daily

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retinaScience DailyCRISPR-Cas9 is a powerful new technology that can target and edit certain aspects of the genome, or the complete set of genetic material of an organism. In the Nature Commu… Continue reading

2017-07-25 Michael Zand NEWS

Merck immunotherapy fails to improve survival in head and neck cancer – Reuters

Merck immunotherapy fails to improve survival in head and neck cancerReuters(Reuters) – Merck & Co said on Monday that its Keytruda immunotherapy failed to extend survival in previously treated patients with advanced head and neck cancer more than … Continue reading

2017-07-24 Michael Zand NEWS

Merck immunotherapy fails to improve survival in head and neck cancer – Reuters

Telegraph.co.ukMerck immunotherapy fails to improve survival in head and neck cancerReuters(Reuters) – Merck & Co said on Monday that its Keytruda immunotherapy failed to extend survival in previously treated patients with advanced head and neck ca… Continue reading

2017-07-24 Michael Zand NEWS

Merck immunotherapy fails to improve survival in head and neck cancer – WHTC

Merck immunotherapy fails to improve survival in head and neck cancerWHTC(Reuters) – Merck & Co said on Monday that its Keytruda immunotherapy failed to extend survival in previously treated patients with advanced head and neck cancer more than the… Continue reading

2017-07-24 Michael Zand NEWS

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina – Medical Xpress

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retinaMedical XpressCRISPR-associated protein Cas9 (white) from Staphylococcus aureus based on Protein Database ID 5AXW. Credit: Thomas Splettstoesser (Wikipedia, CC BY-SA 4.0). A research te… Continue reading

2017-07-24 Michael Zand NEWS

New Gene Therapy Produces Hope for a New Era in Cancer … – Healthline

HealthlineNew Gene Therapy Produces Hope for a New Era in Cancer …HealthlineGene-altering therapy on the cusp of FDA approval may soon be treating children with advanced leukemia.More CAR-T Therapies Sought | GenomeWebGenomeWeball 4 news articles&nbs… Continue reading

2017-07-24 Michael Zand NEWS

1
…
1,450
1,451
1,452
1,453
1,454
…
2,487

Cellectis wins European patent for CRISPR use in T-cells
News-Medical.net
“We have been the first to explore the potential of CRISPR in its early days in various applications, including therapeutics and food, and these early findings ultimately led to the grant of this new patent. While Cellectis has selected TALEN® as the …

and more »

Login

Cart

Tag Archives: The Stem Cell Blog

Rosy future predicted for global synthetic biology industry – WhaTech

Cellectis wins European patent for CRISPR use in T-cells – News-Medical.net

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina – Science Daily

Merck immunotherapy fails to improve survival in head and neck cancer – Reuters

Merck immunotherapy fails to improve survival in head and neck cancer – Reuters

Merck immunotherapy fails to improve survival in head and neck cancer – WHTC

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina – Medical Xpress

New Gene Therapy Produces Hope for a New Era in Cancer … – Healthline